Back to ISIS Stock Lookup
Pages: 1 2 »» Last Page

ISIS Related Analyst Ratings

Mar 21, 2013 01:21 PM Analyst Cautiously Optimistic on ISIS (ISIS) SMN (Rx)
Nov 9, 2012 06:50 AM Cowen Upgrades ISIS Pharmaceuticals (ISIS) to Outperform
Oct 23, 2012 03:59 PM Isis Pharmaceuticals (ISIS) on Traders Radars Ahead of Cramer Mad Money Interview
Oct 19, 2012 01:43 PM Needham Reiterates Buy on ISIS (ISIS) Following Narrow FDA Vote for Approval of Kynamro
Oct 19, 2012 08:47 AM Jefferies Cuts Numbers on ISIS Pharmaceuticals (ISIS) Despite Panel Backing
Oct 17, 2012 09:28 AM Summer Street Cuts ISIS Pharmaceuticals (ISIS) to Neutral
Oct 16, 2012 09:08 AM Piper Jaffray Downgrades ISIS Pharmaceuticals (ISIS) to Overweight
Sep 6, 2012 06:56 AM JMP Securities Starts ISIS Pharmaceuticals (ISIS) at Market Perform
Aug 7, 2012 09:52 AM Canaccord Genuity Maintains Hold and Raises Price Target on ISIS Pharmaceuticals (ISIS)
Jul 19, 2012 07:18 AM Jefferies Downgrades ISIS Pharmaceuticals (ISIS) Two-Notches to Underperform
May 22, 2012 07:20 AM Needham & Company Starts ISIS Pharmaceuticals (ISIS) at Buy; Looking Beyond Kynamro at Significant Pipeline Value
May 9, 2012 09:55 AM Correction - Canaccord Genuity maintains a 'Hold' on ISIS Pharmaceuticals (ISIS)
May 9, 2012 09:52 AM Canaccord Genuity Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Adjusting Estimates After Top & Bottom Line Beat
May 1, 2012 08:06 AM Piper Jaffray Upgrades ISIS Pharmaceuticals (ISIS) to Overweight
Mar 26, 2012 09:04 AM Canaccord Genuity Starts ISIS Pharmaceuticals (ISIS) at Hold
Nov 8, 2011 01:48 PM Jefferies Cuts Price Targets on ISIS Pharmaceuticals (ISIS), Has Enough Cash Through 2014
Sep 7, 2011 05:54 PM BMO Starts Biotech Stocks: AMGN, HGSI, REGN, CELG at Outperform, AMLN, GILD, ARNA at Market Perform, BIIB at Underperform
Aug 8, 2011 08:27 AM Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); 2Q11/Early 3Q11 Review - Mipomersen Application in EU (Submitted) and US (Expected by YE11)
Jun 28, 2011 07:56 AM Global Hunter Securities Starts Aegerion Pharmaceuticals (AEGR) at Buy; Lomitapide – A Potential Best-in-Class Drug
Apr 14, 2011 07:52 AM Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Pipeline Progress Review – Long-Term, Early Stage Programs Are Encouraging
Mar 1, 2011 01:44 PM Barclays Maintains an 'Overweight' on ISIS Pharmaceuticals (ISIS); 4Q10 Update - Mipomersen Filings on Track
Mar 1, 2011 10:31 AM Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Strong Focus on Mipomersen Next Steps by Genzyme, Steady Progress of Early-Stage Pipeline
Feb 17, 2011 10:34 AM Canaccord Genuity Morning Coffee on Sanofi-Aventis (SNY) and Genzyme (GENZ): An Extra $5 Will Help The Medicine Go Down
Jan 11, 2011 07:49 AM Needham & Company Reiterates a 'Hold' on ISIS Pharmaceuticals (ISIS); FDA Views Mipomersen Data as Sufficient to Submit HoFH NDA
Aug 5, 2010 09:51 AM Collins Stewart Downgrades ISIS Pharmaceuticals (ISIS) to Hold
Aug 5, 2010 08:43 AM Piper Jaffray Cuts Isis Pharma (ISIS) to Neutral
Aug 4, 2010 02:45 PM Shares of Isis Pharma (ISIS) Volatile Following Mid-Day Downgrade by Needham
Jul 27, 2010 09:37 AM Morgan Joseph Adds Onyx Pharma (ONXX) to 'Trading List' Following Positive Data on Carfilzomib
Jun 18, 2010 07:56 AM Needham & Company Reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS), Well Positioned to Address Genetic Disorders
Jun 3, 2010 07:38 AM Needham & Company Reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS); Annual Meeting Highlighted
May 28, 2010 01:08 PM Citi 2010 Healthcare Conference Key Takeaways - MRK, PFE, BMY, ISIS, NPSP, & MYGN
May 20, 2010 07:56 AM Needham & Company Reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS); Pipelines to Address Cancer Through Antisense Technology
Apr 15, 2010 07:56 AM Needham & Company reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS); Cardiovascular Program Update – Multiple Well-Characterized Drug Candidates
Feb 11, 2010 09:40 AM Analysts Thoughts On Isis Pharmaceuticals (ISIS) After 19% Sell-Off
Nov 18, 2009 08:16 AM Morgan Joseph Reiterates a 'Buy' on Isis Pharmaceuticals (ISIS); Could Be Acquired by Potential Partners
Nov 18, 2009 07:30 AM Piper Jaffray Maintains an 'Overweight' on ISIS Pharmaceuticals (ISIS); Price Target Cut
Jul 29, 2009 08:33 AM Cantor Fitzgerald Initiates Coverage on Isis Pharmaceuticals (ISIS) with a Buy; Milestones & Potential Near-term Catalysts
May 20, 2009 01:12 PM Barclays Gets Bullish On US Biotechnology Sector (BBH)
Apr 13, 2009 10:45 AM Thomas Weisel Starts Isis Pharma (ISIS) at Overweight
Feb 10, 2009 08:18 AM Citi Initiates Coverage on Isis Pharmaceuticals (ISIS) with a Hold, May Become Core Biotech Holding When Profitable
Jan 9, 2009 09:09 AM Morgan Joseph Initiates Coverage on Isis Pharmaceuticals (ISIS) with a Buy
Dec 16, 2008 01:35 PM Collins Stewart Initiates Coverage on Isis Pharmaceuticals (ISIS) with a Buy
Aug 8, 2008 09:29 AM Needham Upgrades ISIS Pharmaceuticals (ISIS) to Buy
May 27, 2008 08:42 AM BWS Financial Comments Positively on Isis Pharmaceuticals (ISIS); Maintains Buy
May 9, 2008 11:53 AM Color on Boenning & Scattergood Upgrade of ISIS Pharma (ISIS) to Market Perform
May 9, 2008 11:27 AM Boenning & Scattergood Upgrades ISIS Pharmaceuticals (ISIS) to Market Perform
Apr 25, 2008 01:04 PM Needham Downgrades ISIS Pharma (ISIS) to Hold On Mipomersen Delays
Apr 25, 2008 12:22 PM Piper Jaffray Tells Clients To Buy ISIS Pharma (ISIS) On Today's Weakness
Apr 18, 2008 08:20 AM Leerink Swann Downgrades Isis Pharmaceuticals (ISIS) to Market Perform
Mar 14, 2008 08:12 AM Natixis Bleichroeder upgrades ISIS Pharmaceuticals (ISIS) to Hold
Pages: 1 2 »» Last Page

Back to ISIS Stock Lookup